Aytu BioScience Valuation
| AYTU Stock | USD 1.29 0.04 3.20% |
Today, the firm appears to be undervalued. Aytu BioScience shows a prevailing Real Value of $2.91 per share. The current price of the firm is $1.29. Our model approximates the value of Aytu BioScience from analyzing the firm fundamentals such as Current Valuation of 3.41 M, return on equity of -0.23, and Profit Margin of (0.07) % as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Aytu BioScience's price fluctuation is unstable at this time. Calculation of the real value of Aytu BioScience is based on 3 months time horizon. Increasing Aytu BioScience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Aytu BioScience's intrinsic value may or may not be the same as its current market price of 1.29, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.29 | Real 2.91 | Hype 1.28 |
The intrinsic value of Aytu BioScience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aytu BioScience's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Aytu BioScience helps investors to forecast how Aytu stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aytu BioScience more accurately as focusing exclusively on Aytu BioScience's fundamentals will not take into account other important factors: Aytu BioScience Total Value Analysis
Aytu BioScience is presently anticipated to have valuation of 3.41 M with market capitalization of 7.96 M, debt of 15.13 M, and cash on hands of 23.81 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Aytu BioScience fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.41 M | 7.96 M | 15.13 M | 23.81 M |
Aytu BioScience Investor Information
About 31.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.26. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aytu BioScience recorded a loss per share of 2.08. The entity last dividend was issued on the 9th of December 2020. The firm had 1:20 split on the 6th of January 2023. Based on the measurements of operating efficiency obtained from Aytu BioScience's historical financial statements, Aytu BioScience is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Aytu BioScience Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aytu BioScience has an asset utilization ratio of 68.59 percent. This implies that the Company is making $0.69 for each dollar of assets. An increasing asset utilization means that Aytu BioScience is more efficient with each dollar of assets it utilizes for everyday operations.Aytu BioScience Ownership Allocation
30% of Aytu BioScience outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change.Aytu BioScience Profitability Analysis
The company reported the previous year's revenue of 81 M. Net Loss for the year was (15.84 M) with profit before overhead, payroll, taxes, and interest of 50.45 M.About Aytu BioScience Valuation
The stock valuation mechanism determines Aytu BioScience's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Aytu BioScience based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aytu BioScience. We calculate exposure to Aytu BioScience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aytu BioScience's related companies.Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado. Aytu Biopharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 164 people.
Aytu BioScience Growth Indicators
Investing in growth stocks can be very risky. If the company such as Aytu BioScience does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 5.5 M | |
| Forward Price Earnings | 2.1146 |
Additional Tools for Aytu Stock Analysis
When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.